Clinical effi acy observation of Qingwei Jiangni Decoction treatment of 40 cases liver and stomach swelter typegastroesophageal refl x disease

Objective: To investigate the clinical efficacy square Qingwei Jiangni treatment of gastroesophageal reflux. Methods: 80 patients diagnosed with gastroesophageal reflux disease were randomly divided into treatment and control groups. Qingwei Jiangni party application in the treatment group and control group were treated with rabeprazole entericcoated capsules and domperidone. After 8 weeks the clinical effect was observed. Results: The treatment group(92.50%) is higher than the control group(67.50%) and the two groups was statistically significant; in terms of the endoscopic treatment group was significantly better than the control group, the difference was statistically significant. Conclusion: Treatment of liver and stomach with Qingwei Jiangni formula on swelter type of gastroesophageal reflux disease has a significant effect.